NCT lookup

Pull any trial record directly from ClinicalTrials.gov.

Brain and Stress Study
Brain and Stress Study

NCT06044090

CompletedPhase 4

Sponsor: University of North Carolina, Chapel Hill

Conditions: Stress, Psychological, Motivation

Interventions: Minocycline, Placebo

Countries: United States

Motivational deficits such as anhedonia are core to several psychiatric disorders and underlie significant functional impairment. This double-blind, placebo-controlled crossover trial of minocycline, an anti-\[neuro\]inflammatory agent, examines links between chronic stress and responses to a reward-related motivation task. It will evaluate the effects of pharmacologically attenuating neuroinflammation on behavioral responses to a reward-related motivation task in individuals experiencing unemployment. Understanding the effects of neuroinflammation on reward function among individuals experiencing chronic stress represents a critical first step in identifying novel neuroimmune targets for future clinical trials.

Eligibility overview

Sex: ALL

Age: 25 Years to 60 Years

Healthy volunteers: Yes

Study type: INTERVENTIONAL

Eligibility criteria
Inclusion Criteria:

* 25-60 years old
* Unemployed (working less than 20 hours per week)
* Have been unemployed for at least 6 months
* Seeking employment
* Having trouble finding a job (i.e., actively seeking and applying for jobs but not successful in landing a job)
* Reports greater than 5 points on Job Stress Items
* Regular access to a mobile phone

Exclusion Criteria:

* Self-reported physical illnesses: diabetes, cardiovascular diseases, high blood pressure, inflammatory bowel diseases, rheumatoid arthritis, asthma, autoimmune disease, Crohn's disease, ulcerative colitis, lupus
* neurological conditions (e.g., Traumatic Brain Injury, stroke)
* pregnant (as measured by urine pregnancy screen) or breastfeeding
* current use of psychotropic medications
* Current regular recreational drug or alcohol use (i.e., 4 or more times per week)
* chronic diseases that significantly impact inflammatory markers (e.g., cancer)
* known allergies or hypersensitivities to tetracycline antibiotics, aspirin or other NSAIDs
* current antibiotic use
* regular use of steroidal or non-steroidal anti-inflammatory medications (i.e., 2 or more times a week)
Locations (1)
  • Chapel Hill, North Carolina, United States